Login / Signup
An Iron Metabolism-Related SLC22A17 for the Prognostic Value of Gastric Cancer.
Jianming Wei
Xibo Gao
Yulan Qin
Tong Liu
Yani Kang
Published in:
OncoTargets and therapy (2020)
We validated that SLC22A17 associated with iron metabolism could serve as a prognostic biomarker for GC patients.
Keyphrases
</>
end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
iron deficiency
mass spectrometry
drug induced